Medical Device

TSO3 announced it responded to an additional information request from the US Food and Drug Administration.

TSO3 (TSX:TOS) announced it responded to an additional information request from the US Food and Drug Administration.
As quoted in the press release:

This information is in support of the Company’s submission to extend claims of its innovative STERIZONE VP4 Sterilizer to include terminal sterilization of duodenoscopes.

 The Company’s response includes a summary of results from tests evaluating the effect of TSO3‘s sterilization process on specific features incorporated in the design of identified scopes, as well as additional labeling targeted at a selected duodenoscope. Lastly, in its response, the Company defined recommended device inspection and use intervals to assist end-users in their instrument surveillance when performing terminal sterilization of duodenoscopes within the STERIZONE System.

Source: www.newswire.ca

MARKETS

Markets
TSX18861.36-217.28
TSXV617.26-9.08
DOW31097.26+321.83
S&P 5003825.33+39.95
NASD11127.85+99.11
ASX6539.90-28.20

COMMODITIES

Commodities
Gold1809.91-0.13
Silver19.89+0.03
Copper3.61-0.10
Palladium1965.07+9.98
Platinum891.26+2.98
Oil108.46+2.70
Heating Oil3.96+0.13
Natural Gas5.620.00

DOWNLOAD FREE REPORTS

×